SRPT
Sarepta Therapeutics Inc
NASDAQ: SRPT · HEALTHCARE · BIOTECHNOLOGY
$20.67
-1.90% today
Updated 2026-04-29
Market cap
$2.18B
P/E ratio
—
P/S ratio
0.99x
EPS (TTM)
$-7.13
Dividend yield
—
52W range
$10 – $65
Volume
2.9M
Sarepta Therapeutics Inc (SRPT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $56.41M | $40.86M | $38.64M | $25.54M | $60.03M | $45.98M | $54.37M | $204.99M | $291.57M | $295.03M | $273.78M | $424.10M | $1.31B | $1.64B | $1.82B | $2.98B | $3.15B | $3.13B | $3.26B | $3.96B |
| Cash & equivalents | $34.60M | $20.16M | $24.80M | $11.19M | $48.27M | $33.59M | $39.90M | $187.66M | $256.96M | $73.55M | $80.30M | $122.42M | $599.69M | $370.83M | $835.08M | $1.50B | $2.12B | $966.78M | $428.43M | $1.10B |
| Current assets | $48.65M | $33.94M | $28.71M | $17.04M | $51.31M | $37.84M | $45.18M | $193.91M | $270.81M | $247.80M | $224.54M | $373.48M | $1.23B | $1.43B | $1.47B | $2.49B | $2.60B | $2.56B | $2.58B | $3.07B |
| Total liabilities | $2.75M | $3.15M | $12.26M | $9.80M | $36.40M | $48.79M | $23.35M | $81.31M | $44.38M | $47.38M | $83.44M | $87.41M | $518.75M | $609.80M | $1.00B | $2.22B | $2.22B | $2.74B | $2.41B | $2.44B |
| Current liabilities | $2.75M | $3.15M | $9.75M | $7.29M | $33.51M | $45.86M | $20.60M | $78.89M | $35.97M | $36.87M | $62.29M | $75.42M | $88.33M | $173.69M | $264.77M | $416.03M | $452.73M | $619.60M | $653.66M | $731.68M |
| Long-term debt | — | — | $2.07M | $2.00M | $1.92M | $1.84M | $1.76M | $1.67M | $1.58M | $3.74M | $14.97M | $6.04M | $424.88M | $420.55M | $681.90M | $992.49M | $1.10B | $1.54B | $1.13B | $1.14B |
| Shareholder equity | $53.66M | $37.71M | $26.38M | $15.73M | $23.63M | $-2.82M | $31.02M | $123.68M | $247.19M | $247.65M | $190.35M | $336.69M | $789.22M | $1.03B | $818.19M | $761.76M | $928.01M | $384.95M | $859.34M | $1.53B |
| Retained earnings | $-172.65M | $-203.72M | $-226.36M | $-250.31M | $-275.47M | $-307.65M | $-309.96M | $-431.25M | $-543.24M | $-679.02M | $-899.05M | $-1.17B | $-1.22B | $-1.58B | $-2.29B | $-2.85B | $-3.21B | $-3.91B | $-4.45B | $-4.21B |
| Accounts receivable | $1.24M | $51498.00 | $2.87M | $4.97M | $2.08M | $3.22M | $3.63M | $4.71M | $3.53M | $2.42M | $3.98M | $5.23M | $29.47M | $49.04M | $93.94M | $138.58M | $171.64M | $261.60M | $436.98M | $649.73M |
| Inventory | — | — | — | — | — | — | $-3.63M | $1.00 | $7.25M | $33.47M | $26.87M | $12.81M | $83.61M | $125.44M | $171.38M | $231.96M | $186.21M | $203.97M | $322.86M | $749.96M |
| Goodwill | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |